Headquarters: Hamburg, Hamburg, Germany
Industry: End-to-End Drug Development
Employee Number: 1001-5000
Estimated Revenue: $100M to $500M
Investors Number: 10.0
Investor Type: Not Classified
Funding Status: IPO
Acquisitions Number: Made Acquisitions
Number Of Exists: 2
Technology: Biopharma, Biotechnology, Pharmaceutical
Last Funding Type: Post-IPO Debt
Founded Date: 1993-01-01
Total Funding: 733436691.0
Last Funding Date: 2023-02-10